07:00 , Jun 16, 2003 |  BioCentury  |  Finance

Ebb & Flow

The doomsday mood in European biotech is lifting. Since the market bottom in March, BioCentury's European and London indices now are tracking the upswing in U.S. biotech stocks. The BioCentury 100 Index, which consists primarily...
08:00 , Feb 1, 2000 |  BC Extra  |  Financial News

Deltagen raises $22.5 million

Deltagen (Menlo Park, Calif.), which is developing its DeltaBase database of mammalian genes relevant to small molecule therapeutic discovery, raised $22.5 million in a venture round. Investors included Boston Millennia Partners; The Sprout Group; Baccharis...
07:00 , Apr 13, 1998 |  BioCentury  |  Emerging Company Profile

Deltagen Inc.

Deltagen Inc. San Carlos, Calif. Technology: Functional analysis of gene families using knockout mice Disease focus: NA Clinical status: NA Founded: 1997 by William Matthews and Mark Moore Corporate partners: Tularik Inc. University collaborators: None...